Arthritis medicines and cardiovascular events - "House of coxibs"

被引：80

作者：

Topol, EJ

机构：

[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA

[2] Cleveland Clin, Lerner Coll Med, Off Provost, Cleveland, OH 44106 USA

[3] Case Western Reserve Univ, Cleveland, OH 44106 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2005年 / 293卷 / 03期

关键词：

D O I：

10.1001/jama.293.3.366

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：366 / 368

页数：3

共 21 条

[1] Selective COX-2 inhibition improves endothelial function in coronary artery disease [J].

Chenevard, R ;

Hürlimann, D ;

Béchir, M ;

Enseleit, F ;

Spieker, L ;

Hermann, M ;

Riesen, W ;

Gay, S ;

Gay, RE ;

Neidhart, M ;

Michel, B ;

Lüscher, TF ;

Noll, G ;

Ruschitzka, F .

CIRCULATION, 2003, 107 (03) :405-409

[2] Over-the-counter pain reliever and aspirin use within a sample of long-term cyclooxygenase 2 users [J].

Cox, ER ;

Frisse, M ;

Behm, A ;

Fairman, KA .

ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (11) :1243-1246

[3] Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial [J].

Farkouh, ME ;

Kirshner, H ;

Harrington, RA ;

Ruland, S ;

Verheugt, FW ;

Schnitzer, T ;

Burmester, GR ;

Mysler, E ;

Hochberg, MC ;

Doherty, M ;

Ehrsam, E ;

Gitton, X ;

Krammer, G ;

Mellein, B ;

Gimona, A ;

Matchaba, P ;

Hawkey, CJ ;

Chesebro, JH .

LANCET, 2004, 364 (9435) :675-684

[4] Postmarketing surveillance - Lack of vigilance, lack of trust [J].

Fontanarosa, PB ;

Rennie, D ;

DeAngelis, CD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (21) :2647-2650

[5]

GRAHAM DJ, 2004, PHARMACOEPIDEM DR S, V13, pS287

[6]

Harris Gardiner, 2004, N Y Times Web, pA19

[7] Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries [J].

Hennan, JK ;

Huang, JB ;

Barrett, TD ;

Driscoll, EM ;

Willens, DE ;

Park, AM ;

Crofford, LJ ;

Lucchesi, BR .

CIRCULATION, 2001, 104 (07) :820-825

[8] Risk of cardiovascular events and rofecoxib: cumulative meta-analysis [J].

Juni, P ;

Nartey, L ;

Reichenbach, S ;

Sterchi, R ;

Dieppe, PA ;

Egger, M .

LANCET, 2004, 364 (9450) :2021-2029

[9]

KIMMEL SE, 2004, ANN INTERN MED 1207

[10] Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study [J].

Mamdani, M ;

Juurlink, DN ;

Lee, DS ;

Rochon, PA ;

Kopp, A ;

Naglie, G ;

Austin, PC ;

Laupacis, A ;

Stukel, TA .

LANCET, 2004, 363 (9423) :1751-1756

← 1 2 3 →